Celularity Inc.

Celularity Inc.verified

CELU

Price:

$1.973

Market Cap:

$47.46M

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic ...[Read more]

Industry

Biotechnology

IPO Date

2019-08-08

Stock Exchange

NASDAQ

Ticker

CELU

The Enterprise Value as of December 2025 (TTM) for Celularity Inc. (CELU) is 112.66M

According to Celularity Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 112.66M. This represents a change of -2.22% compared to the average of 115.22M of the last 4 quarters.

Celularity Inc. (CELU) Historical Enterprise Value (quarterly & annually)

How has CELU Enterprise Value performed in the past?

The mean historical Enterprise Value of Celularity Inc. over the last ten years is 913.21M. The current 112.66M Enterprise Value has changed 1.13% with respect to the historical average. Over the past ten years (40 quarters), CELU's Enterprise Value was at its highest in in the June 2021 quarter at 1.28B. The Enterprise Value was at its lowest in in the December 2022 quarter at 51.62M.

Quarterly (TTM)
Annual

Average

913.21M

Median

631.23M

Minimum

109.19M

Maximum

3.52B

Celularity Inc. (CELU) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Celularity Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 23.76%

Maximum Annual Enterprise Value = 3.52B

Minimum Annual Increase = -77.36%

Minimum Annual Enterprise Value = 109.19M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024113.63M4.07%
2023109.19M-52.96%
2022232.11M-63.23%
2021631.23M-36.04%
2020986.90M23.76%
2019797.43M-77.36%

Celularity Inc. (CELU) Average Enterprise Value

How has CELU Enterprise Value performed in the past?

The current Enterprise Value of Celularity Inc. (CELU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

151.64M

5-year avg

414.61M

10-year avg

913.21M

Celularity Inc. (CELU) Enterprise Value vs. Peers

How is CELU’s Enterprise Value compared to its peers?

Celularity Inc.’s Enterprise Value is greater than BioAtla, Inc. (47.72M), greater than Reviva Pharmaceuticals Holdings, Inc. (30.06M), greater than Annovis Bio, Inc. (-17038803690.00), greater than FibroGen, Inc. (103.14M), greater than Actinium Pharmaceuticals, Inc. (-7013958.00), less than BioXcel Therapeutics, Inc. (136.96M), greater than Kezar Life Sciences, Inc. (20.85M), greater than PolyPid Ltd. (31.37M), greater than Tempest Therapeutics, Inc. (9.57M), greater than Generation Bio Co. (71.40M),

Build a custom stock screener for Celularity Inc. (CELU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celularity Inc. (CELU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Celularity Inc.'s Enterprise Value?

What is the highest Enterprise Value for Celularity Inc. (CELU)?

What is the 3-year average Enterprise Value for Celularity Inc. (CELU)?

What is the 5-year average Enterprise Value for Celularity Inc. (CELU)?

How does the current Enterprise Value for Celularity Inc. (CELU) compare to its historical average?